[HTML][HTML] Modulation of redox-sensitive transcription factors with polyphenols as pathogenetically grounded approach in therapy of systemic inflammatory response
V Kostenko, O Akimov, O Gutnik, H Kostenko… - Heliyon, 2023 - cell.com
One of the adverse outcomes of acute inflammatory response is progressing to the chronic
stage or transforming into an aggressive process, which can develop rapidly and result in …
stage or transforming into an aggressive process, which can develop rapidly and result in …
[HTML][HTML] Pharmacological and therapeutic applications of esculetin
Esculetin is a coumarin compound, which belongs to the class of benzopyrone enriched in
various plants such as Sonchus grandifolius, Aesculus turbinata, etc. Free radicals lead to …
various plants such as Sonchus grandifolius, Aesculus turbinata, etc. Free radicals lead to …
Caffeic acid modified nanomicelles inhibit articular cartilage deterioration and reduce disease severity in experimental inflammatory arthritis
Inflammation plays an important role in the development of rheumatoid arthritis (RA). NR4A1
is an anti-inflammatory orphan nuclear receptor involved in protection from inflammatory …
is an anti-inflammatory orphan nuclear receptor involved in protection from inflammatory …
[HTML][HTML] NF-κB signaling and inflammation—Drug repurposing to treat inflammatory disorders?
A Roberti, LE Chaffey, DR Greaves - Biology, 2022 - mdpi.com
Simple Summary Since its first description 35 years ago, the transcription factor NF-κB
(nuclear factor κ-light-chain-enhancer of activated B cells) has been shown to be a key …
(nuclear factor κ-light-chain-enhancer of activated B cells) has been shown to be a key …
[HTML][HTML] Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
T Balendran, K Lim, JA Hamilton… - Frontiers in …, 2023 - frontiersin.org
Rheumatoid arthritis (RA) is a destructive inflammatory autoimmune disease that causes
pain and disability. Many of the currently available drugs for treating RA patients are aimed …
pain and disability. Many of the currently available drugs for treating RA patients are aimed …
[HTML][HTML] Exosomes derived from mesenchymal stem cells primed with disease-condition-serum improved therapeutic efficacy in a mouse rheumatoid arthritis model …
EW Choi, IR Lim, JH Park, J Song, B Choi… - Stem Cell Research & …, 2023 - Springer
Backgrounds Rheumatoid arthritis (RA) is a chronic and systemic autoimmune disease
characterized by synovial inflammation-mediated progressive destruction of the cartilage …
characterized by synovial inflammation-mediated progressive destruction of the cartilage …
[HTML][HTML] A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway
SB Yoon, H Hong, HJ Lim, JH Choi, YP Choi… - … Pharmaceutica Sinica B, 2023 - Elsevier
Abstract Interleukin-1 receptor-associated kinase 4 (IRAK4) is a pivotal enzyme in the Toll-
like receptor (TLR)/MYD88 dependent signaling pathway, which is highly activated in …
like receptor (TLR)/MYD88 dependent signaling pathway, which is highly activated in …
[HTML][HTML] Exploring the Therapeutic Potential of Ammodaucus leucotrichus Seed Extracts: A Multi-Faceted Analysis of Phytochemical Composition, Anti-Inflammatory …
C Djehiche, N Benzidane, H Djeghim, M Tebboub… - Pharmaceuticals, 2024 - mdpi.com
Ammodaucus leucotrichus exhibits promising pharmacological activity, hinting at anti-
inflammatory and anti-arthritic effects. This study investigated seed extracts from …
inflammatory and anti-arthritic effects. This study investigated seed extracts from …
Schisandrin B ameliorates adjuvant-induced arthritis in rats via modulation of inflammatory mediators, oxidative stress, and HIF-1α/VEGF pathway
X Chen, C Liu, J Deng, T Xia, X Zhang… - Journal of Pharmacy …, 2024 - academic.oup.com
Abstract Objectives Schisandrin B (Sch B) has been shown to possess anti-inflammatory
and antioxidant properties, however, its antirheumatoid arthritis properties and potential …
and antioxidant properties, however, its antirheumatoid arthritis properties and potential …
Carrier-free nanodrug targeting glucose metabolism for enhanced rheumatoid arthritis treatment
T Chen, X Lin, D Li, L Pan, X Qin, W Ye, Z Luo… - Colloids and Surfaces B …, 2024 - Elsevier
Dramatically increased glycolysis has been found in inflamed joints in rheumatoid arthritis
(RA) due to the increased demand for energy and biosynthetic precursors to support the …
(RA) due to the increased demand for energy and biosynthetic precursors to support the …